Summary
45 / 100 · Bulios Score
What speaks for it
- The share price is below the Bulios Fair Price.
- Analysts expect revenue to grow by 18% this fiscal year.
- Out of every 100 USD of revenue, 16 USD is left as free cash.
What to watch
- The company made a loss over the last 12 months.
- It passes only 3 of the 9 points of the Piotroski financial health test.
- Revenue growth is slowing: 9.6% a year over the last 3 years against 16% over 5 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 16% a year over 5 years. Over the last 3 years it grew by 9.6% a year. For the next fiscal year analysts expect revenue to grow by 18%.
Growth in detailDoes it make money?
ReasonablyOver the last 12 months it made a loss of $146.8M.
Profitability in detailIs it financially healthy?
YesRepaying all its debt would take 4.4 years of free cash flow. It holds more cash than debt. The debt score is low because of the debt-to-equity ratio (1.2x).
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Neutral- Buy 17
- Hold 18
- Sell 0
Today's price within the analysts' price targets
The average target of $50.75 is 4.0% above today's price. 49% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Software as a Service 74%
- Subscription and Circulation 18%
- Maintenance 8.2%
By region
- UNITED STATES 71%
- EMEA 21%
- Rest of World 7.9%
Software as a Service brings in 74% of revenue.
Segments in detail